Welcome to our dedicated page for TRANSACT TECHNOLOGIES SEC filings (Ticker: TACT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
TransAct Technologies Incorporated filings document the public-company disclosures of a Nasdaq-listed provider of software-driven technology, integrated printing solutions, consumables, and services. Form 8-K reports cover operating results and material agreements, including facility leases and BOHA! source-code and licensing arrangements tied to the company’s foodservice technology platform.
Proxy materials describe board governance, stockholder meeting procedures, executive compensation, pay-versus-performance data, and equity-award valuation matters. Other filings identify the company’s common stock registration on the NASDAQ Global Market under TACT and record bylaw amendments, corporate governance provisions, and periodic material-event disclosures.
TRANSACT TECHNOLOGIES INC director Audrey Dunning exercised equity awards to receive additional common shares. On May 4, 2026, 1,700 Restricted Stock Units granted on May 4, 2022 under the company’s 2014 Equity Incentive Plan converted into 1,700 shares of common stock on a one-for-one basis. Following this vesting and conversion, she directly holds 19,300 shares of common stock. The RSUs were compensation-related awards that vested annually and did not involve an open-market purchase or sale.
TRANSACT TECHNOLOGIES INC Chief Technology Officer Brent Richtsmeier reported a routine equity compensation event. On May 1, 2026, 6,325 Restricted Stock Units converted into an equal number of common shares at no exercise price, reflecting vesting under the company’s 2014 Equity Incentive Plan.
Following the conversion, he directly holds 36,323 shares of common stock and 18,975 Restricted Stock Units. The RSUs were originally issued on May 1, 2025 and vest 25% each year starting on the first anniversary of the grant date.
TransAct Technologies Incorporated has called a virtual 2026 Annual Meeting of Stockholders for May 26, 2026 at 10:00 a.m. Eastern Time via www.virtualshareholdermeeting.com/TACT2026. Holders of its common stock at the close of business on April 1, 2026, when 10,276,279 shares were outstanding, may vote.
Stockholders will vote on electing six directors for one-year terms, ratifying CBIZ CPAs P.C. as independent auditor for 2026, and approving on an advisory basis the compensation of named executive officers. The proxy statement details ownership by major holders, related-party transactions, board independence, committee structure, governance policies and executive pay framework.
TransAct Technologies Incorporated extended the lease for its primary operating facility at 20 Bomax Drive in Ithaca, New York. The Lease Amendment adds a new term running from April 1, 2026 through September 30, 2031. For the first two years of this extended term, monthly base rent is set at $40,022.13, which is lower than the previous monthly base rent of $43,100.75. Beginning April 1, 2028, the rent escalates annually, rising to $40,822.57 for the period April 1, 2028 through March 31, 2029 and reaching $43,347.04 for the final six months of the extended term.
TransAct Technologies CEO John Dillon reported open-market purchases of company stock through a trust. A trust associated with him bought 29,098 shares of common stock on March 13 at a weighted average price of $3.56 per share, in multiple trades between $3.30 and $3.60. On March 16, the trust bought an additional 70,902 shares at a weighted average price of $3.49, in trades between $3.39 and $3.60, bringing the trust’s indirect holdings to 100,000 shares. Dillon also directly owns 168,318 shares of common stock, which now reflects an extra 1,100 shares that had been omitted from earlier filings due to an administrative error.
TransAct Technologies filed an amended Form 4 to correct a director equity award. On February 24, 2026, Daniel M. Friedberg received a grant of 15,759 Restricted Stock Units under the 2014 Equity Incentive Plan, rather than the 14,700 units previously reported.
The RSUs cliff vest on the first anniversary of the grant and convert into common stock on a one-for-one basis. 325 Capital LLC is entitled to the economic interest in securities granted for Mr. Friedberg’s board service, and multiple affiliated entities may be deemed to share beneficial ownership, which they each disclaim except for any pecuniary interest.
TransAct Technologies director Emanuel N. Hilario corrected a previously reported equity award. An amended Form 4 now shows he received a grant of 15,759 Restricted Stock Units on February 24, 2026, replacing the originally reported 14,700 units. These RSUs cliff vest on the first anniversary of the grant and convert into common stock on a one-for-one basis. Following this correction, his reported RSU holdings from this grant total 15,759 units.
TransAct Technologies director Haydee Olinger received a corrected equity grant. An amended Form 4 now shows a grant of 15,759 Restricted Stock Units on February 24, 2026, instead of the 14,700 units previously reported. These RSUs cliff vest on the first anniversary of the grant and convert into common stock on a one-for-one basis.
TransAct Technologies director Randall S. Friedman received a grant of 15,759 Restricted Stock Units on February 24, 2026 as equity compensation. This Form 4 amendment corrects an earlier report that mistakenly showed 14,700 units. The RSUs were issued under the company’s 2014 Equity Incentive Plan, as amended and restated.
The units cliff vest on the first anniversary of the grant date and then convert into common stock on a one-for-one basis. Following this grant, Friedman is reported as directly holding 15,759 Restricted Stock Units tied to TransAct common stock.